Virtual Payment Terminals Market
Virtual payment (POS) terminals is a Web-based version of a credit card swipe device that allows ... Read More
Palatability is a term used to describe how well a dog or cat likes the taste, smell, and texture of a food. A premium pet food manufacturer spends a considerable amount of time conducting controlled feeding studies to determine the right combination of ingredients and processing techniques to produce a nutritious, palatable food.
This report contains market size and forecasts of Home Blood Pressure Monitoring Devices in global, including the following market information:
Global Home Blood Pressure Monitoring Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Home Blood Pressure Monitoring Devices Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Home Blood Pressure Monitoring Devices companies in 2021 (%)
The global Home Blood Pressure Monitoring Devices market was valued at 901.8 million in 2021 and is projected to reach US$ 1128.3 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Upper Arm Monitor Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Home Blood Pressure Monitoring Devices include Omron Healthcare, A&D Company, Hill-Rom, SunTech Medical, Rossmax International, Philips, Beurer GmbH, American Diagnostic Corporation and Spengler. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Home Blood Pressure Monitoring Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Home Blood Pressure Monitoring Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Home Blood Pressure Monitoring Devices Market Segment Percentages, by Type, 2021 (%)
Upper Arm Monitor
Wrist Monitor
Accessories
Global Home Blood Pressure Monitoring Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Home Blood Pressure Monitoring Devices Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacies
Other
Global Home Blood Pressure Monitoring Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Home Blood Pressure Monitoring Devices Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Home Blood Pressure Monitoring Devices revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Home Blood Pressure Monitoring Devices revenues share in global market, 2021 (%)
Key companies Home Blood Pressure Monitoring Devices sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Home Blood Pressure Monitoring Devices sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Omron Healthcare
A&D Company
Hill-Rom
SunTech Medical
Rossmax International
Philips
Beurer GmbH
American Diagnostic Corporation
Spengler
Virtual payment (POS) terminals is a Web-based version of a credit card swipe device that allows ... Read More
The advent of virtual classrooms and e-learning courses has increased the need for interactive wh ... Read More
Breast cancer is one of the most common malignant tumors in women, which poses a great threat to ... Read More
An increasing number of hormone therapies have made refractory breast cancer resistant to treatme ... Read More